|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn657415811 |
003 |
OCoLC |
005 |
20231117044442.0 |
006 |
m o d |
007 |
cr un||||a|a|| |
008 |
100823s1993 ne a ob 001 0 eng d |
040 |
|
|
|a OCLCE
|b eng
|e pn
|c OCLCE
|d OCLCQ
|d OPELS
|d N$T
|d NLGGC
|d YDXCP
|d E7B
|d OCLCQ
|d UAB
|d OCLCO
|d OCLCA
|d OTZ
|d OCLCO
|d OCLCF
|d OCLCQ
|d STF
|d OCLCO
|d OCLCA
|d UKAHL
|d LUN
|d S2H
|d OCLCO
|d OCLCQ
|d OCLCO
|d COM
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 621127710
|a 899003118
|a 974617479
|a 974671219
|a 987781904
|a 1100944076
|a 1257376784
|
020 |
|
|
|a 9780444886552
|q (electronic bk.)
|
020 |
|
|
|a 0444886559
|q (electronic bk.)
|
020 |
|
|
|a 9781483164632
|q (electronic bk.)
|
020 |
|
|
|a 1483164632
|q (electronic bk.)
|
035 |
|
|
|a (OCoLC)657415811
|z (OCoLC)621127710
|z (OCoLC)899003118
|z (OCoLC)974617479
|z (OCoLC)974671219
|z (OCoLC)987781904
|z (OCoLC)1100944076
|z (OCoLC)1257376784
|
042 |
|
|
|a dlr
|
050 |
|
4 |
|a QP572.P4
|b D88 1993
|
060 |
|
4 |
|a W1
|b PH272L v.19 1993
|
060 |
|
4 |
|a WK 185
|b D979s 1993
|
070 |
|
|
|a RS402.P42
|b v.19
|
072 |
|
0 |
|a X300
|
072 |
|
0 |
|a X380
|
072 |
|
7 |
|a MED
|x 075000
|2 bisacsh
|
072 |
|
7 |
|a SCI
|x 036000
|2 bisacsh
|
082 |
0 |
4 |
|a 612/.015746
|2 20
|
084 |
|
|
|a VK 8560
|2 rvk
|
100 |
1 |
|
|a Dutta, A. S.
|q (Anand S.)
|
245 |
1 |
0 |
|a Small peptides :
|b chemistry, biology, and clinical studies /
|c A.S. Dutta.
|
260 |
|
|
|a Amsterdam ;
|a New York :
|b Elsevier,
|c 1993.
|
300 |
|
|
|a 1 online resource (xvi, 616 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Pharmacochemistry library ;
|v v. 19
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Angiotensin II -- Receptor subtypes of angiotensin II -- Agonist analogues of angiotensin II -- Peptide antagonists of angiotensin II -- Non-peptide antagonists of angiotensin II -- Non-peptide antagonists of angiotensin II acting at the AT₂ receptor -- Bombesin/gastrin-releasing peptide -- Antagonists of bombesin/GRP -- Conformationally restricted analogues of bombesin -- Bombesin/GRP antagonists and cancer -- Bradykinin analogues -- Receptor subtypes of bradykinin -- Agonist analogues of bradykinin -- Antagonists of bradykinin -- Biological profile of HOE 140 and related antagonists -- Side effects associated with bradykinin antagonists -- Cholecystokinin analogues -- Distribution and biological functions of cholecystokinin -- Cholecystokinin receptor subtypes and receptor-selective ligands -- Peptide antagonists of cholecystokinin and gastrin -- Non-peptide antagonists of CCK and gastrin -- Enkephalin analogues -- Enzymic inactivation of enkephalins -- Early structure activity relationship studies -- Agonist analogues displaying analgesic activity.
|
505 |
0 |
|
|a (cont) Analogues with improved selectivity for the mu and delta receptors -- Antagonists of enkephalins -- Luteinising hormone releasing hormone -- Enzymic degradation of LHRH -- SAR of LHRH agonists -- SAR of LHRH antagonists -- LHRH antagonists and histamine release -- Hexapeptide derivatives as LHRH antagonists -- Ketaconazole derivatives as LHRH antagonists -- Formulations of LHRH and the analogues -- Pharmacological and clinical studies with LHRH agonists and antagonists -- Somatostatin -- Enzymatic degradation of somatostatin and analogues agonist analogues of somatostatin. SAR studies -- Clinical applications of somatostatin analogues -- Tachykinins -- Substance P, neurokinin A and neurokinin B -- Receptor subtypes of tachykinins -- SAR of the mammalian tachykinins -- Antagonists of substance P -- Antagonists of neurokinin A and neurokinin B -- Non-peptide antagonists of the tachykinins -- Biological studies using SP analogues -- Inhibitors of aspartyl proteases. 1.renin -- Inhibitors of renin -- Inhibitors of aspartyl proteases. 2. HIV protease.
|
505 |
0 |
|
|a (cont) Nature of the enzyme -- Chemical approaches used in the design of inhibitors -- Non-peptide inhibitors of HIV protease -- Metallopeptidase (ace, enkephalinase and atriopeptidase) inhibitors -- Inhibitors of angiotensin converting enzyme -- Inhibitors of enkephalin degrading dipeptidyl-carboxypeptidase (enkephalinase) -- Inhibitors of atrial natriuretic factor (ANF) degrading enzyme -- Formulation of peptides -- Polymeric controlled drug delivery systems (depot formulations) -- Improvements in the oral delivery of peptides -- Intranasal administration of peptides -- Transdermal iontophoretic drug delivery of peptides -- Administration of peptides by ocular, vaginal and rectal routes.
|
588 |
0 |
|
|a Print version record.
|
506 |
|
|
|3 Use copy
|f Restrictions unspecified
|2 star
|5 MiAaHDL
|
533 |
|
|
|a Electronic reproduction.
|b [Place of publication not identified] :
|c HathiTrust Digital Library,
|d 2010.
|5 MiAaHDL
|
538 |
|
|
|a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.
|u http://purl.oclc.org/DLF/benchrepro0212
|5 MiAaHDL
|
583 |
1 |
|
|a digitized
|c 2010
|h HathiTrust Digital Library
|l committed to preserve
|2 pda
|5 MiAaHDL
|
650 |
|
0 |
|a Peptide hormones
|x Agonists.
|
650 |
|
0 |
|a Peptide hormones
|x Antagonists.
|
650 |
|
0 |
|a Neuropeptides
|x Agonists.
|
650 |
|
0 |
|a Neuropeptides
|x Antagonists.
|
650 |
|
0 |
|a Protein drugs.
|
650 |
|
0 |
|a Hormones.
|
650 |
|
2 |
|a Hormones
|0 (DNLM)D006728
|
650 |
|
2 |
|a Peptides
|x antagonists & inhibitors
|0 (DNLM)D010455Q000037
|
650 |
|
2 |
|a Neuropeptides
|x antagonists & inhibitors
|0 (DNLM)D009479Q000037
|
650 |
|
2 |
|a Proteins
|x therapeutic use
|0 (DNLM)D011506Q000627
|
650 |
|
2 |
|a Receptors, Peptide
|0 (DNLM)D018000
|
650 |
|
6 |
|a Hormones peptidiques
|0 (CaQQLa)201-0023590
|x Agonistes.
|0 (CaQQLa)201-0374387
|
650 |
|
6 |
|a Hormones peptidiques
|0 (CaQQLa)201-0023590
|x Antagonistes.
|0 (CaQQLa)201-0374866
|
650 |
|
6 |
|a Neuropeptides
|0 (CaQQLa)201-0023738
|x Agonistes.
|0 (CaQQLa)201-0374387
|
650 |
|
6 |
|a Neuropeptides
|0 (CaQQLa)201-0023738
|x Antagonistes.
|0 (CaQQLa)201-0374866
|
650 |
|
6 |
|a M�edicaments prot�eiques.
|0 (CaQQLa)201-0249096
|
650 |
|
6 |
|a Hormones.
|0 (CaQQLa)201-0017163
|
650 |
|
7 |
|a hormone.
|2 aat
|0 (CStmoGRI)aat300265405
|
650 |
|
7 |
|a MEDICAL
|x Physiology.
|2 bisacsh
|
650 |
|
7 |
|a SCIENCE
|x Life Sciences
|x Human Anatomy & Physiology.
|2 bisacsh
|
650 |
|
7 |
|a Hormones
|2 fast
|0 (OCoLC)fst00960219
|
650 |
|
7 |
|a Protein drugs
|2 fast
|0 (OCoLC)fst01079679
|
650 |
|
7 |
|a Antagonist
|2 gnd
|0 (DE-588)4198647-7
|
650 |
|
7 |
|a Arzneimittel
|2 gnd
|0 (DE-588)4003115-9
|
650 |
|
7 |
|a Neuropeptide
|2 gnd
|0 (DE-588)4041895-9
|
650 |
|
7 |
|a Peptide
|2 gnd
|0 (DE-588)4045125-2
|
650 |
|
7 |
|a Peptidhormon
|2 gnd
|0 (DE-588)4045127-6
|
653 |
0 |
|
|a Peptides
|
776 |
0 |
8 |
|i Print version:
|a Dutta, A.S. (Anand S.).
|t Small peptides.
|d Amsterdam ; New York : Elsevier, 1993
|w (DLC) 93011629
|w (OCoLC)28498594
|
830 |
|
0 |
|a Pharmacochemistry library ;
|v v. 19.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780444886552
|z Texto completo
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/bookseries/01657208/19
|z Texto completo
|